XML 40 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated statements of cash flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (61,099) $ (33,199) $ (13,990)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 3,288 772 302
Loss on disposal of property and equipment 156   14
Changes in right of use assets and operating lease liabilities, net (18) 1,179 (9)
Non-cash loss on foreign currency remeasurement 3   0
Non-cash share-based compensation 6,317 2,992 719
Changes in operating assets and liabilities      
Prepaid expenses and other current assets (9,771) (3,120) (2,566)
Accounts payable (2,572) 5,258 548
Income taxes payable (7) 7  
Accrued expenses and other liabilities 4,937 3,045 873
Other long-term liability 47 614  
Deferred tax assets (22) (4)  
Other assets (543) (2,796) (33)
Net cash used in operating activities (59,284) (25,252) (14,142)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of property and equipment (7,634) (11,847) (942)
Net cash used in investing activities (7,634) (11,847) (942)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Issuance of ADRs in initial public offering, net of issuance costs 160,755    
Proceeds of issuance of convertible preferred shares, net of issuance costs   113,825 93,622
Payments of initial public offering costs   (121)  
Net cash provided by financing activities 160,755 113,704 93,622
Effect of exchange rate changes on cash equivalents and restricted cash (5,334) 3,650 8,373
Net increase in cash 88,503 80,255 86,911
Cash, cash equivalents and restricted cash, beginning of year 177,849 97,594 10,683
Cash, cash equivalents and restricted cash, end of year 266,352 177,849 97,594
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:      
Right of use assets obtained in exchange for new operating lease liabilities 314 15,846 457
Property and equipment purchases in accrued expenses 726 285 343
Issuance costs of convertible preferred shares included in accounts payable     192
Deferred offering costs included in accrued expenses   826  
Cash and cash equivalents 266,319 $ 177,849 $ 97,594
Restricted cash $ 33